Charles Li
Director/Board Member bij EKSO BIONICS HOLDINGS, INC.
Vermogen: 37 275 $ op 31-03-2024
Profiel
Charles Li is currently an Independent Director at Ekso Bionics Holdings, Inc. and the Chief Business Officer at Angel Pharmaceuticals Co., Ltd.
He holds a doctorate degree from Harvard University and an undergraduate degree from Xi'an Jiaotong University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-04-2023 | 27 408 ( 0.15% ) | 37 275 $ | 31-03-2024 |
Actieve functies van Charles Li
| Bedrijven | Functie | Begin |
|---|---|---|
| EKSO BIONICS HOLDINGS, INC. | Director/Board Member | 11-03-2018 |
Angel Pharmaceuticals Co., Ltd.
 Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 10-10-2020 |
Opleiding van Charles Li
| Harvard University | Doctorate Degree |
| Xi'an Jiaotong University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EKSO BIONICS HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Health Technology |
